Descon Oxychem（DOL）株式概要デスコンオキシケム社は、パキスタン国内および国際的なパルプ・製紙、化粧品、その他産業向けの過酸化水素および関連製品の製造、調達、販売に従事している。 詳細DOL ファンダメンタル分析スノーフレーク・スコア評価1/6将来の成長0/6過去の実績1/6財務の健全性6/6配当金2/6リスク分析11.92%の配当は、利益やフリーキャッシュフローによって十分にカバーされていない 高いレベルの非現金収入 利益率(8.8%)は昨年より低い(13.9%) 意味のある時価総額がありません ( PKR6B )すべてのリスクチェックを見るDOL Community Fair Values Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.Your Fair ValuePK₨Current PricePK₨33.5779.6% 割高 内在価値ディスカウントGrowth estimate overAnnual revenue growth rate5 Yearstime period%/yrDecreaseIncreasePastFuture09b2016201920222025202620282031Revenue PK₨8.6bEarnings PK₨759.0mAdvancedSet Fair ValueView all narrativesDescon Oxychem Limited 競合他社Nimir ResinsSymbol: KASE:NRSLMarket cap: PK₨5.0bBiafo IndustriesSymbol: KASE:BIFOMarket cap: PK₨6.3bArchroma PakistanSymbol: KASE:ARPLMarket cap: PK₨13.6bPakistan SyntheticsSymbol: KASE:PSYLMarket cap: PK₨12.4b価格と性能株価の高値、安値、推移の概要Descon Oxychem過去の株価現在の株価PK₨33.5752週高値PK₨41.0052週安値PK₨25.36ベータ0.561ヶ月の変化26.97%3ヶ月変化11.64%1年変化1.33%3年間の変化34.60%5年間の変化19.47%IPOからの変化299.81%最新ニュースお知らせ • Apr 15Descon Oxychem Limited to Report Q3, 2026 Results on Apr 23, 2026Descon Oxychem Limited announced that they will report Q3, 2026 results on Apr 23, 2026Valuation Update With 7 Day Price Move • Mar 13Investor sentiment deteriorates as stock falls 16%After last week's 16% share price decline to PK₨27.28, the stock trades at a trailing P/E ratio of 7.5x. Average trailing P/E is 10x in the Chemicals industry in Pakistan. Total returns to shareholders of 57% over the past three years.Declared Dividend • Feb 28First half dividend of PK₨2.00 announcedDividend of PK₨2.00 is the same as last year. Ex-date: 9th March 2026 Payment date: 2nd April 2026 Dividend yield will be 13%, which is about the same as the industry average. Sustainability & Growth Dividend is covered by earnings (55% earnings payout ratio) but the company has no free cash flows available, indicating it may be using cash reserves or debt to pay the dividend. The dividend has increased by an average of 13% per year over the past 7 years. However, payments have been volatile during that time. Earnings per share has grown by 11% over the last 5 years. Unless this trend reverses, it should provide support to the dividend and adequate earnings cover.Reported Earnings • Feb 26Second quarter 2026 earnings released: EPS: PK₨0.79 (vs PK₨1.75 in 2Q 2025)Second quarter 2026 results: EPS: PK₨0.79 (down from PK₨1.75 in 2Q 2025). Revenue: PK₨1.21b (down 28% from 2Q 2025). Net income: PK₨138.9m (down 55% from 2Q 2025). Profit margin: 11% (down from 18% in 2Q 2025). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has fallen by 25% per year but the company’s share price has increased by 13% per year, which means it is well ahead of earnings.お知らせ • Feb 16Descon Oxychem Limited to Report Q2, 2026 Results on Feb 24, 2026Descon Oxychem Limited announced that they will report Q2, 2026 results at 12:30 PM, Pakistan Standard Time on Feb 24, 2026Reported Earnings • Oct 25First quarter 2026 earnings released: EPS: PK₨0.78 (vs PK₨1.08 in 1Q 2025)First quarter 2026 results: EPS: PK₨0.78 (down from PK₨1.08 in 1Q 2025). Revenue: PK₨1.28b (down 16% from 1Q 2025). Net income: PK₨135.7m (down 28% from 1Q 2025). Profit margin: 11% (down from 13% in 1Q 2025). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has fallen by 21% per year but the company’s share price has increased by 15% per year, which means it is well ahead of earnings.最新情報をもっと見るRecent updatesお知らせ • Apr 15Descon Oxychem Limited to Report Q3, 2026 Results on Apr 23, 2026Descon Oxychem Limited announced that they will report Q3, 2026 results on Apr 23, 2026Valuation Update With 7 Day Price Move • Mar 13Investor sentiment deteriorates as stock falls 16%After last week's 16% share price decline to PK₨27.28, the stock trades at a trailing P/E ratio of 7.5x. Average trailing P/E is 10x in the Chemicals industry in Pakistan. Total returns to shareholders of 57% over the past three years.Declared Dividend • Feb 28First half dividend of PK₨2.00 announcedDividend of PK₨2.00 is the same as last year. Ex-date: 9th March 2026 Payment date: 2nd April 2026 Dividend yield will be 13%, which is about the same as the industry average. Sustainability & Growth Dividend is covered by earnings (55% earnings payout ratio) but the company has no free cash flows available, indicating it may be using cash reserves or debt to pay the dividend. The dividend has increased by an average of 13% per year over the past 7 years. However, payments have been volatile during that time. Earnings per share has grown by 11% over the last 5 years. Unless this trend reverses, it should provide support to the dividend and adequate earnings cover.Reported Earnings • Feb 26Second quarter 2026 earnings released: EPS: PK₨0.79 (vs PK₨1.75 in 2Q 2025)Second quarter 2026 results: EPS: PK₨0.79 (down from PK₨1.75 in 2Q 2025). Revenue: PK₨1.21b (down 28% from 2Q 2025). Net income: PK₨138.9m (down 55% from 2Q 2025). Profit margin: 11% (down from 18% in 2Q 2025). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has fallen by 25% per year but the company’s share price has increased by 13% per year, which means it is well ahead of earnings.お知らせ • Feb 16Descon Oxychem Limited to Report Q2, 2026 Results on Feb 24, 2026Descon Oxychem Limited announced that they will report Q2, 2026 results at 12:30 PM, Pakistan Standard Time on Feb 24, 2026Reported Earnings • Oct 25First quarter 2026 earnings released: EPS: PK₨0.78 (vs PK₨1.08 in 1Q 2025)First quarter 2026 results: EPS: PK₨0.78 (down from PK₨1.08 in 1Q 2025). Revenue: PK₨1.28b (down 16% from 1Q 2025). Net income: PK₨135.7m (down 28% from 1Q 2025). Profit margin: 11% (down from 13% in 1Q 2025). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has fallen by 21% per year but the company’s share price has increased by 15% per year, which means it is well ahead of earnings.Upcoming Dividend • Oct 06Upcoming dividend of PK₨2.00 per shareEligible shareholders must have bought the stock before 13 October 2025. Payment date: 12 November 2025. Payout ratio is on the higher end at 81%, however this is supported by cash flows. Trailing yield: 10%. Within top quartile of Pakistani dividend payers (7.2%). Higher than average of industry peers (7.1%).Reported Earnings • Sep 06Full year 2025 earnings released: EPS: PK₨4.91 (vs PK₨2.90 in FY 2024)Full year 2025 results: EPS: PK₨4.91 (up from PK₨2.90 in FY 2024). Revenue: PK₨6.00b (up 4.5% from FY 2024). Net income: PK₨860.2m (up 70% from FY 2024). Profit margin: 14% (up from 8.8% in FY 2024). The increase in margin was primarily driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 14% per year but the company’s share price has increased by 19% per year, which means it is well ahead of earnings.お知らせ • Sep 05Descon Oxychem Limited, Annual General Meeting, Oct 22, 2025Descon Oxychem Limited, Annual General Meeting, Oct 22, 2025. Location: descon headquarters, 18-km, ferozepur road., lahore PakistanNew Risk • Aug 09New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Pakistani stocks, typically moving 8.4% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Share price has been volatile over the past 3 months (8.4% average weekly change). Market cap is less than US$100m (PK₨5.96b market cap, or US$21.1m).お知らせ • Jul 02Descon Oxychem Limited Announces Chief Executive Officer Changes, Effective June 30, 2025Descon Oxychem Limited announced that Mr. Muhammad Mohsin Zia, Chief Executive Officer of the Company, tendered his resignation from the post of Chief Executive Officer with effect from June 30, 2025. Mr. Yasir Siddique Sheikh, has been appointed as Chief Executive Officer in place of Mr. Muhammad Mohsin Zia for the balance un-expired term with an immediate effect.New Risk • May 27New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Pakistani stocks, typically moving 8.2% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Share price has been volatile over the past 3 months (8.2% average weekly change). Market cap is less than US$100m (PK₨5.80b market cap, or US$20.6m).Buy Or Sell Opportunity • May 26Now 25% undervaluedOver the last 90 days, the stock has risen 20% to PK₨33.13. The fair value is estimated to be PK₨44.15, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 9.1% over the last 3 years. Earnings per share has declined by 6.3%.Valuation Update With 7 Day Price Move • May 16Investor sentiment improves as stock rises 21%After last week's 21% share price gain to PK₨28.97, the stock trades at a trailing P/E ratio of 6.1x. Average forward P/E is 16x in the Chemicals industry in Pakistan. Total returns to shareholders of 172% over the past three years.Upcoming Dividend • Feb 24Upcoming dividend of PK₨2.00 per shareEligible shareholders must have bought the stock before 03 March 2025. Payment date: 26 March 2025. Payout ratio is a comfortable 72% but the company is not cash flow positive. Trailing yield: 7.1%. Lower than top quartile of Pakistani dividend payers (9.4%). Lower than average of industry peers (8.0%).Reported Earnings • Oct 19First quarter 2025 earnings released: EPS: PK₨1.08 (vs PK₨1.14 in 1Q 2024)First quarter 2025 results: EPS: PK₨1.08 (down from PK₨1.14 in 1Q 2024). Revenue: PK₨1.51b (up 1.0% from 1Q 2024). Net income: PK₨189.8m (down 4.7% from 1Q 2024). Profit margin: 13% (in line with 1Q 2024). Revenue is forecast to grow 8.5% p.a. on average during the next 2 years, compared to a 6.8% growth forecast for the Chemicals industry in Pakistan. Over the last 3 years on average, earnings per share has increased by 10% per year but the company’s share price has fallen by 4% per year, which means it is significantly lagging earnings.Upcoming Dividend • Oct 01Upcoming dividend of PK₨2.00 per shareEligible shareholders must have bought the stock before 08 October 2024. Payment date: 06 November 2024. Trailing yield: 9.8%. Lower than top quartile of Pakistani dividend payers (12%). In line with average of industry peers (9.1%).New Risk • Sep 17New major risk - Financial data availabilityThe company has not reported any financial data. This is considered a major risk. With no or incomplete audited reported financial data, it is virtually impossible to assess the company's investment potential. Currently, the following risks have been identified for the company: Major Risk No financial data reported. Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Market cap is less than US$100m (PK₨3.65b market cap, or US$13.1m).お知らせ • Sep 11Descon Oxychem Limited, Annual General Meeting, Oct 16, 2024Descon Oxychem Limited, Annual General Meeting, Oct 16, 2024. Location: at descon headquarters., 18-km,ferozepur road, lahore PakistanBuy Or Sell Opportunity • May 13Now 22% overvaluedOver the last 90 days, the stock has fallen 5.5% to PK₨21.28. The fair value is estimated to be PK₨17.48, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 31% over the last 3 years. Earnings per share has grown by 36%.Reported Earnings • Feb 28Second quarter 2024 earnings released: EPS: PK₨0.38 (vs PK₨2.79 in 2Q 2023)Second quarter 2024 results: EPS: PK₨0.38 (down from PK₨2.79 in 2Q 2023). Revenue: PK₨1.40b (down 21% from 2Q 2023). Net income: PK₨66.1m (down 87% from 2Q 2023). Profit margin: 4.7% (down from 27% in 2Q 2023). The decrease in margin was primarily driven by lower revenue. Over the last 3 years on average, earnings per share has increased by 47% per year but the company’s share price has fallen by 10% per year, which means it is significantly lagging earnings.Valuation Update With 7 Day Price Move • Feb 16Investor sentiment deteriorates as stock falls 19%After last week's 19% share price decline to PK₨19.94, the stock trades at a trailing P/E ratio of 3.2x. Average trailing P/E is 5x in the Chemicals industry in Pakistan. Total loss to shareholders of 12% over the past three years.Upcoming Dividend • Oct 03Upcoming dividend of PK₨2.00 per share at 17% yieldEligible shareholders must have bought the stock before 10 October 2023. Payment date: 08 November 2023. Payout ratio is a comfortable 50% and this is well supported by cash flows. Trailing yield: 17%. Within top quartile of Pakistani dividend payers (14%). In line with average of industry peers (15%).Reported Earnings • Sep 27Full year 2023 earnings released: EPS: PK₨8.00 (vs PK₨2.69 in FY 2022)Full year 2023 results: EPS: PK₨8.00 (up from PK₨2.69 in FY 2022). Revenue: PK₨6.72b (up 58% from FY 2022). Net income: PK₨1.40b (up 197% from FY 2022). Profit margin: 21% (up from 11% in FY 2022). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 54% per year but the company’s share price has fallen by 15% per year, which means it is significantly lagging earnings.Reported Earnings • Apr 29Third quarter 2023 earnings released: EPS: PK₨1.67 (vs PK₨0.15 in 3Q 2022)Third quarter 2023 results: EPS: PK₨1.67 (up from PK₨0.15 in 3Q 2022). Revenue: PK₨1.70b (up 73% from 3Q 2022). Net income: PK₨293.1m (up PK₨267.4m from 3Q 2022). Profit margin: 17% (up from 2.6% in 3Q 2022). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 50% per year but the company’s share price has only increased by 3% per year, which means it is significantly lagging earnings growth.Valuation Update With 7 Day Price Move • Mar 20Investor sentiment improves as stock rises 19%After last week's 19% share price gain to PK₨27.34, the stock trades at a trailing P/E ratio of 3.9x. Average trailing P/E is 7x in the Chemicals industry in Pakistan. Total returns to shareholders of 127% over the past three years.Reported Earnings • Feb 24Second quarter 2023 earnings released: EPS: PK₨2.79 (vs PK₨1.36 in 2Q 2022)Second quarter 2023 results: EPS: PK₨2.79 (up from PK₨1.36 in 2Q 2022). Revenue: PK₨1.78b (up 57% from 2Q 2022). Net income: PK₨489.0m (up 105% from 2Q 2022). Profit margin: 27% (up from 21% in 2Q 2022). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 37% per year but the company’s share price has only increased by 11% per year, which means it is significantly lagging earnings growth.Board Change • Nov 16Less than half of directors are independentThere is 1 new director who has joined the board in the last 3 years. The new board member was not an independent director. The company's board is composed of: 1 new director. 6 experienced directors. 1 highly experienced director. 3 independent directors (5 non-independent directors). Independent Director Haroon Waheed was the last independent director to join the board, commencing their role in 2018. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.Valuation Update With 7 Day Price Move • Nov 03Investor sentiment improved over the past weekAfter last week's 16% share price gain to PK₨25.28, the stock trades at a trailing P/E ratio of 4.6x. Average trailing P/E is 7x in the Chemicals industry in Pakistan. Total returns to shareholders of 116% over the past three years.Reported Earnings • Oct 28First quarter 2023 earnings released: EPS: PK₨2.96 (vs PK₨0.13 in 1Q 2022)First quarter 2023 results: EPS: PK₨2.96 (up from PK₨0.13 in 1Q 2022). Revenue: PK₨1.70b (up 116% from 1Q 2022). Net income: PK₨518.8m (up PK₨496.4m from 1Q 2022). Profit margin: 31% (up from 2.8% in 1Q 2022). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 21% per year whereas the company’s share price has increased by 19% per year.Upcoming Dividend • Oct 03Upcoming dividend of PK₨2.00 per shareEligible shareholders must have bought the stock before 10 October 2022. Payment date: 10 November 2022. Payout ratio is a comfortable 74% and this is well supported by cash flows. Trailing yield: 9.4%. Lower than top quartile of Pakistani dividend payers (11%). Lower than average of industry peers (12%).Reported Earnings • Sep 28Full year 2022 earnings released: EPS: PK₨2.69 (vs PK₨1.59 in FY 2021)Full year 2022 results: EPS: PK₨2.69 (up from PK₨1.59 in FY 2021). Revenue: PK₨4.25b (up 52% from FY 2021). Net income: PK₨470.9m (up 69% from FY 2021). Profit margin: 11% (up from 9.9% in FY 2021). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 5% per year but the company’s share price has increased by 18% per year, which means it is well ahead of earnings.Valuation Update With 7 Day Price Move • Aug 03Investor sentiment improved over the past weekAfter last week's 17% share price gain to PK₨17.50, the stock trades at a trailing P/E ratio of 9.3x. Average trailing P/E is 5x in the Chemicals industry in Pakistan. Total returns to shareholders of 62% over the past three years.Reported Earnings • Apr 30Third quarter 2022 earnings released: EPS: PK₨0.15 (vs PK₨0.75 in 3Q 2021)Third quarter 2022 results: EPS: PK₨0.15 (down from PK₨0.75 in 3Q 2021). Revenue: PK₨982.1m (up 24% from 3Q 2021). Net income: PK₨25.7m (down 80% from 3Q 2021). Profit margin: 2.6% (down from 17% in 3Q 2021). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has fallen by 22% per year but the company’s share price has increased by 2% per year, which means it is well ahead of earnings.Board Change • Apr 27Less than half of directors are independentThere is 1 new director who has joined the board in the last 3 years. The new board member was not an independent director. The company's board is composed of: 1 new director. 6 experienced directors. 1 highly experienced director. 3 independent directors (5 non-independent directors). Independent Director Haroon Waheed was the last independent director to join the board, commencing their role in 2018. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.Reported Earnings • Feb 21Second quarter 2022 earnings: Revenues and EPS in line with analyst expectationsSecond quarter 2022 results: EPS: PK₨1.36 (up from PK₨0.52 in 2Q 2021). Revenue: PK₨1.14b (up 61% from 2Q 2021). Net income: PK₨238.1m (up 162% from 2Q 2021). Profit margin: 21% (up from 13% in 2Q 2021). The increase in margin was driven by higher revenue. Revenue was in line with analyst estimates. Over the last 3 years on average, earnings per share has fallen by 28% per year but the company’s share price has remained flat, which means it is well ahead of earnings.Reported Earnings • Oct 27First quarter 2022 earnings released: EPS PK₨0.13 (vs PK₨0.099 in 1Q 2021)The company reported a strong first quarter result with improved earnings, revenues and profit margins. First quarter 2022 results: Revenue: PK₨788.3m (up 27% from 1Q 2021). Net income: PK₨22.4m (up 59% from 1Q 2021). Profit margin: 2.8% (up from 2.3% in 1Q 2021). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 34% per year but the company’s share price has only fallen by 10% per year, which means it has not declined as severely as earnings.Upcoming Dividend • Oct 07Upcoming dividend of PK₨1.00 per shareEligible shareholders must have bought the stock before 14 October 2021. Payment date: 15 November 2021. Trailing yield: 4.4%. Lower than top quartile of Pakistani dividend payers (10%). Lower than average of industry peers (11%).Reported Earnings • Sep 09Full year 2021 earnings released: EPS PK₨1.59 (vs PK₨2.95 in FY 2020)The company reported a soft full year result with weaker earnings and profit margins, although revenues improved. Full year 2021 results: Revenue: PK₨2.80b (up 6.2% from FY 2020). Net income: PK₨278.7m (down 33% from FY 2020). Profit margin: 9.9% (down from 16% in FY 2020). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has fallen by 26% per year but the company’s share price has only fallen by 2% per year, which means it has not declined as severely as earnings.Reported Earnings • Apr 24Third quarter 2021 earnings released: EPS PK₨0.75 (vs PK₨0.81 in 3Q 2020)The company reported a solid third quarter result with improved earnings and revenues, although profit margins were weaker. Third quarter 2021 results: Revenue: PK₨793.1m (up 11% from 3Q 2020). Net income: PK₨130.7m (up 2.7% from 3Q 2020). Profit margin: 17% (down from 18% in 3Q 2020). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has fallen by 13% per year but the company’s share price has increased by 13% per year, which means it is well ahead of earnings.Valuation Update With 7 Day Price Move • Mar 10Investor sentiment deteriorated over the past weekAfter last week's 20% share price decline to PK₨23.43, the stock is trading at a trailing P/E ratio of 10.5x, down from the previous P/E ratio of 13.1x. This compares to an average P/E of 9x in the Chemicals industry in Pakistan. Total returns to shareholders over the past three years are 54%.Reported Earnings • Feb 28Second quarter 2021 earnings released: EPS PK₨0.52 (vs PK₨0.75 in 2Q 2020)The company reported a decent second quarter result with improved earnings and profit margins, although revenues were weaker. Second quarter 2021 results: Revenue: PK₨705.0m (down 5.0% from 2Q 2020). Net income: PK₨90.9m (up 2.9% from 2Q 2020). Profit margin: 13% (up from 12% in 2Q 2020). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has fallen by 4% per year but the company’s share price has increased by 23% per year, which means it is well ahead of earnings.Is New 90 Day High Low • Feb 20New 90-day low: PK₨30.83The company is down 5.0% from its price of PK₨32.33 on 20 November 2020. The Pakistani market is up 12% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 6.0% over the same period.Reported Earnings • Oct 26First quarter earnings releasedOver the last 12 months the company has reported total profits of PK₨378.3m, up 74% from the prior year. Total revenue was PK₨2.63b over the last 12 months, up 1.2% from the prior year.Reported Earnings • Oct 02Full year earnings released - EPS PK₨3.42Over the last 12 months the company has reported total profits of PK₨418.4m, up 6.6% from the prior year. Total revenue was PK₨2.64b over the last 12 months, down 2.3% from the prior year. Profit margins were 16%, which is higher than the 14% margin from last year. The increase in margin was driven by lower expenses.Is New 90 Day High Low • Sep 25New 90-day high: PK₨48.36The company is up 67% from its price of PK₨28.97 on 26 June 2020. The Pakistani market is up 21% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 10.0% over the same period.株主還元DOLPK ChemicalsPK 市場7D7.0%5.6%5.3%1Y1.3%34.5%31.5%株主還元を見る業界別リターン: DOL過去 1 年間で34.5 % の収益を上げたPK Chemicals業界を下回りました。リターン対市場: DOLは、過去 1 年間で31.5 % のリターンを上げたPK市場を下回りました。価格変動Is DOL's price volatile compared to industry and market?DOL volatilityDOL Average Weekly Movement8.0%Chemicals Industry Average Movement8.3%Market Average Movement8.4%10% most volatile stocks in PK Market11.1%10% least volatile stocks in PK Market5.7%安定した株価: DOL 、 PK市場と比較して、過去 3 か月間で大きな価格変動はありませんでした。時間の経過による変動: DOLの 週次ボラティリティ ( 8% ) は過去 1 年間安定しています。会社概要設立従業員CEO（最高経営責任者ウェブサイト2004105Yasir Sheikhwww.descon.com/dol/aboutデスコンオキシケム社は、パキスタン国内および国際的に、紙パルプ、化粧品、その他産業向けの過酸化水素および関連製品の製造、調達、販売を行っている。同社の製品には、繊維産業の漂白ニーズ向け原料Textox、製紙/パルプベース事業向けPrintox、機械および関連機械の除菌用食品グレード化学薬品Aseptox、低濃度除菌剤Sanidol、鉱業向けDolox、化粧品産業向けCosmox、養鶏産業の給水および操業ニーズ向けCareoxなどがある。また、化学品および関連製品、洗剤・消毒剤、水処理・浄化用化学品、原材料の輸出入・貿易にも携わっている。デスコンオキシケムは2004年に設立され、パキスタンのラホールに本社を置いている。もっと見るDescon Oxychem Limited 基礎のまとめDescon Oxychem の収益と売上を時価総額と比較するとどうか。DOL 基礎統計学時価総額PK₨5.88b収益（TTM）PK₨447.46m売上高(TTM)PK₨5.06b13.1xPER（株価収益率1.2xP/SレシオDOL は割高か？公正価値と評価分析を参照収益と収入最新の決算報告書（TTM）に基づく主な収益性統計DOL 損益計算書（TTM）収益PK₨5.06b売上原価PK₨4.09b売上総利益PK₨974.95mその他の費用PK₨527.49m収益PK₨447.46m直近の収益報告Mar 31, 2026次回決算日該当なし一株当たり利益（EPS）2.56グロス・マージン19.25%純利益率8.84%有利子負債／自己資本比率33.2%DOL の長期的なパフォーマンスは？過去の実績と比較を見る配当金11.9%現在の配当利回り156%配当性向View Valuation企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/05/25 10:07終値2026/05/25 00:00収益2026/03/31年間収益2025/06/30データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Descon Oxychem Limited 0 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。1 アナリスト機関null nullBMA Capital Management Ltd.
お知らせ • Apr 15Descon Oxychem Limited to Report Q3, 2026 Results on Apr 23, 2026Descon Oxychem Limited announced that they will report Q3, 2026 results on Apr 23, 2026
Valuation Update With 7 Day Price Move • Mar 13Investor sentiment deteriorates as stock falls 16%After last week's 16% share price decline to PK₨27.28, the stock trades at a trailing P/E ratio of 7.5x. Average trailing P/E is 10x in the Chemicals industry in Pakistan. Total returns to shareholders of 57% over the past three years.
Declared Dividend • Feb 28First half dividend of PK₨2.00 announcedDividend of PK₨2.00 is the same as last year. Ex-date: 9th March 2026 Payment date: 2nd April 2026 Dividend yield will be 13%, which is about the same as the industry average. Sustainability & Growth Dividend is covered by earnings (55% earnings payout ratio) but the company has no free cash flows available, indicating it may be using cash reserves or debt to pay the dividend. The dividend has increased by an average of 13% per year over the past 7 years. However, payments have been volatile during that time. Earnings per share has grown by 11% over the last 5 years. Unless this trend reverses, it should provide support to the dividend and adequate earnings cover.
Reported Earnings • Feb 26Second quarter 2026 earnings released: EPS: PK₨0.79 (vs PK₨1.75 in 2Q 2025)Second quarter 2026 results: EPS: PK₨0.79 (down from PK₨1.75 in 2Q 2025). Revenue: PK₨1.21b (down 28% from 2Q 2025). Net income: PK₨138.9m (down 55% from 2Q 2025). Profit margin: 11% (down from 18% in 2Q 2025). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has fallen by 25% per year but the company’s share price has increased by 13% per year, which means it is well ahead of earnings.
お知らせ • Feb 16Descon Oxychem Limited to Report Q2, 2026 Results on Feb 24, 2026Descon Oxychem Limited announced that they will report Q2, 2026 results at 12:30 PM, Pakistan Standard Time on Feb 24, 2026
Reported Earnings • Oct 25First quarter 2026 earnings released: EPS: PK₨0.78 (vs PK₨1.08 in 1Q 2025)First quarter 2026 results: EPS: PK₨0.78 (down from PK₨1.08 in 1Q 2025). Revenue: PK₨1.28b (down 16% from 1Q 2025). Net income: PK₨135.7m (down 28% from 1Q 2025). Profit margin: 11% (down from 13% in 1Q 2025). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has fallen by 21% per year but the company’s share price has increased by 15% per year, which means it is well ahead of earnings.
お知らせ • Apr 15Descon Oxychem Limited to Report Q3, 2026 Results on Apr 23, 2026Descon Oxychem Limited announced that they will report Q3, 2026 results on Apr 23, 2026
Valuation Update With 7 Day Price Move • Mar 13Investor sentiment deteriorates as stock falls 16%After last week's 16% share price decline to PK₨27.28, the stock trades at a trailing P/E ratio of 7.5x. Average trailing P/E is 10x in the Chemicals industry in Pakistan. Total returns to shareholders of 57% over the past three years.
Declared Dividend • Feb 28First half dividend of PK₨2.00 announcedDividend of PK₨2.00 is the same as last year. Ex-date: 9th March 2026 Payment date: 2nd April 2026 Dividend yield will be 13%, which is about the same as the industry average. Sustainability & Growth Dividend is covered by earnings (55% earnings payout ratio) but the company has no free cash flows available, indicating it may be using cash reserves or debt to pay the dividend. The dividend has increased by an average of 13% per year over the past 7 years. However, payments have been volatile during that time. Earnings per share has grown by 11% over the last 5 years. Unless this trend reverses, it should provide support to the dividend and adequate earnings cover.
Reported Earnings • Feb 26Second quarter 2026 earnings released: EPS: PK₨0.79 (vs PK₨1.75 in 2Q 2025)Second quarter 2026 results: EPS: PK₨0.79 (down from PK₨1.75 in 2Q 2025). Revenue: PK₨1.21b (down 28% from 2Q 2025). Net income: PK₨138.9m (down 55% from 2Q 2025). Profit margin: 11% (down from 18% in 2Q 2025). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has fallen by 25% per year but the company’s share price has increased by 13% per year, which means it is well ahead of earnings.
お知らせ • Feb 16Descon Oxychem Limited to Report Q2, 2026 Results on Feb 24, 2026Descon Oxychem Limited announced that they will report Q2, 2026 results at 12:30 PM, Pakistan Standard Time on Feb 24, 2026
Reported Earnings • Oct 25First quarter 2026 earnings released: EPS: PK₨0.78 (vs PK₨1.08 in 1Q 2025)First quarter 2026 results: EPS: PK₨0.78 (down from PK₨1.08 in 1Q 2025). Revenue: PK₨1.28b (down 16% from 1Q 2025). Net income: PK₨135.7m (down 28% from 1Q 2025). Profit margin: 11% (down from 13% in 1Q 2025). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has fallen by 21% per year but the company’s share price has increased by 15% per year, which means it is well ahead of earnings.
Upcoming Dividend • Oct 06Upcoming dividend of PK₨2.00 per shareEligible shareholders must have bought the stock before 13 October 2025. Payment date: 12 November 2025. Payout ratio is on the higher end at 81%, however this is supported by cash flows. Trailing yield: 10%. Within top quartile of Pakistani dividend payers (7.2%). Higher than average of industry peers (7.1%).
Reported Earnings • Sep 06Full year 2025 earnings released: EPS: PK₨4.91 (vs PK₨2.90 in FY 2024)Full year 2025 results: EPS: PK₨4.91 (up from PK₨2.90 in FY 2024). Revenue: PK₨6.00b (up 4.5% from FY 2024). Net income: PK₨860.2m (up 70% from FY 2024). Profit margin: 14% (up from 8.8% in FY 2024). The increase in margin was primarily driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 14% per year but the company’s share price has increased by 19% per year, which means it is well ahead of earnings.
お知らせ • Sep 05Descon Oxychem Limited, Annual General Meeting, Oct 22, 2025Descon Oxychem Limited, Annual General Meeting, Oct 22, 2025. Location: descon headquarters, 18-km, ferozepur road., lahore Pakistan
New Risk • Aug 09New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Pakistani stocks, typically moving 8.4% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Share price has been volatile over the past 3 months (8.4% average weekly change). Market cap is less than US$100m (PK₨5.96b market cap, or US$21.1m).
お知らせ • Jul 02Descon Oxychem Limited Announces Chief Executive Officer Changes, Effective June 30, 2025Descon Oxychem Limited announced that Mr. Muhammad Mohsin Zia, Chief Executive Officer of the Company, tendered his resignation from the post of Chief Executive Officer with effect from June 30, 2025. Mr. Yasir Siddique Sheikh, has been appointed as Chief Executive Officer in place of Mr. Muhammad Mohsin Zia for the balance un-expired term with an immediate effect.
New Risk • May 27New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Pakistani stocks, typically moving 8.2% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Share price has been volatile over the past 3 months (8.2% average weekly change). Market cap is less than US$100m (PK₨5.80b market cap, or US$20.6m).
Buy Or Sell Opportunity • May 26Now 25% undervaluedOver the last 90 days, the stock has risen 20% to PK₨33.13. The fair value is estimated to be PK₨44.15, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 9.1% over the last 3 years. Earnings per share has declined by 6.3%.
Valuation Update With 7 Day Price Move • May 16Investor sentiment improves as stock rises 21%After last week's 21% share price gain to PK₨28.97, the stock trades at a trailing P/E ratio of 6.1x. Average forward P/E is 16x in the Chemicals industry in Pakistan. Total returns to shareholders of 172% over the past three years.
Upcoming Dividend • Feb 24Upcoming dividend of PK₨2.00 per shareEligible shareholders must have bought the stock before 03 March 2025. Payment date: 26 March 2025. Payout ratio is a comfortable 72% but the company is not cash flow positive. Trailing yield: 7.1%. Lower than top quartile of Pakistani dividend payers (9.4%). Lower than average of industry peers (8.0%).
Reported Earnings • Oct 19First quarter 2025 earnings released: EPS: PK₨1.08 (vs PK₨1.14 in 1Q 2024)First quarter 2025 results: EPS: PK₨1.08 (down from PK₨1.14 in 1Q 2024). Revenue: PK₨1.51b (up 1.0% from 1Q 2024). Net income: PK₨189.8m (down 4.7% from 1Q 2024). Profit margin: 13% (in line with 1Q 2024). Revenue is forecast to grow 8.5% p.a. on average during the next 2 years, compared to a 6.8% growth forecast for the Chemicals industry in Pakistan. Over the last 3 years on average, earnings per share has increased by 10% per year but the company’s share price has fallen by 4% per year, which means it is significantly lagging earnings.
Upcoming Dividend • Oct 01Upcoming dividend of PK₨2.00 per shareEligible shareholders must have bought the stock before 08 October 2024. Payment date: 06 November 2024. Trailing yield: 9.8%. Lower than top quartile of Pakistani dividend payers (12%). In line with average of industry peers (9.1%).
New Risk • Sep 17New major risk - Financial data availabilityThe company has not reported any financial data. This is considered a major risk. With no or incomplete audited reported financial data, it is virtually impossible to assess the company's investment potential. Currently, the following risks have been identified for the company: Major Risk No financial data reported. Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Market cap is less than US$100m (PK₨3.65b market cap, or US$13.1m).
お知らせ • Sep 11Descon Oxychem Limited, Annual General Meeting, Oct 16, 2024Descon Oxychem Limited, Annual General Meeting, Oct 16, 2024. Location: at descon headquarters., 18-km,ferozepur road, lahore Pakistan
Buy Or Sell Opportunity • May 13Now 22% overvaluedOver the last 90 days, the stock has fallen 5.5% to PK₨21.28. The fair value is estimated to be PK₨17.48, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 31% over the last 3 years. Earnings per share has grown by 36%.
Reported Earnings • Feb 28Second quarter 2024 earnings released: EPS: PK₨0.38 (vs PK₨2.79 in 2Q 2023)Second quarter 2024 results: EPS: PK₨0.38 (down from PK₨2.79 in 2Q 2023). Revenue: PK₨1.40b (down 21% from 2Q 2023). Net income: PK₨66.1m (down 87% from 2Q 2023). Profit margin: 4.7% (down from 27% in 2Q 2023). The decrease in margin was primarily driven by lower revenue. Over the last 3 years on average, earnings per share has increased by 47% per year but the company’s share price has fallen by 10% per year, which means it is significantly lagging earnings.
Valuation Update With 7 Day Price Move • Feb 16Investor sentiment deteriorates as stock falls 19%After last week's 19% share price decline to PK₨19.94, the stock trades at a trailing P/E ratio of 3.2x. Average trailing P/E is 5x in the Chemicals industry in Pakistan. Total loss to shareholders of 12% over the past three years.
Upcoming Dividend • Oct 03Upcoming dividend of PK₨2.00 per share at 17% yieldEligible shareholders must have bought the stock before 10 October 2023. Payment date: 08 November 2023. Payout ratio is a comfortable 50% and this is well supported by cash flows. Trailing yield: 17%. Within top quartile of Pakistani dividend payers (14%). In line with average of industry peers (15%).
Reported Earnings • Sep 27Full year 2023 earnings released: EPS: PK₨8.00 (vs PK₨2.69 in FY 2022)Full year 2023 results: EPS: PK₨8.00 (up from PK₨2.69 in FY 2022). Revenue: PK₨6.72b (up 58% from FY 2022). Net income: PK₨1.40b (up 197% from FY 2022). Profit margin: 21% (up from 11% in FY 2022). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 54% per year but the company’s share price has fallen by 15% per year, which means it is significantly lagging earnings.
Reported Earnings • Apr 29Third quarter 2023 earnings released: EPS: PK₨1.67 (vs PK₨0.15 in 3Q 2022)Third quarter 2023 results: EPS: PK₨1.67 (up from PK₨0.15 in 3Q 2022). Revenue: PK₨1.70b (up 73% from 3Q 2022). Net income: PK₨293.1m (up PK₨267.4m from 3Q 2022). Profit margin: 17% (up from 2.6% in 3Q 2022). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 50% per year but the company’s share price has only increased by 3% per year, which means it is significantly lagging earnings growth.
Valuation Update With 7 Day Price Move • Mar 20Investor sentiment improves as stock rises 19%After last week's 19% share price gain to PK₨27.34, the stock trades at a trailing P/E ratio of 3.9x. Average trailing P/E is 7x in the Chemicals industry in Pakistan. Total returns to shareholders of 127% over the past three years.
Reported Earnings • Feb 24Second quarter 2023 earnings released: EPS: PK₨2.79 (vs PK₨1.36 in 2Q 2022)Second quarter 2023 results: EPS: PK₨2.79 (up from PK₨1.36 in 2Q 2022). Revenue: PK₨1.78b (up 57% from 2Q 2022). Net income: PK₨489.0m (up 105% from 2Q 2022). Profit margin: 27% (up from 21% in 2Q 2022). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 37% per year but the company’s share price has only increased by 11% per year, which means it is significantly lagging earnings growth.
Board Change • Nov 16Less than half of directors are independentThere is 1 new director who has joined the board in the last 3 years. The new board member was not an independent director. The company's board is composed of: 1 new director. 6 experienced directors. 1 highly experienced director. 3 independent directors (5 non-independent directors). Independent Director Haroon Waheed was the last independent director to join the board, commencing their role in 2018. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.
Valuation Update With 7 Day Price Move • Nov 03Investor sentiment improved over the past weekAfter last week's 16% share price gain to PK₨25.28, the stock trades at a trailing P/E ratio of 4.6x. Average trailing P/E is 7x in the Chemicals industry in Pakistan. Total returns to shareholders of 116% over the past three years.
Reported Earnings • Oct 28First quarter 2023 earnings released: EPS: PK₨2.96 (vs PK₨0.13 in 1Q 2022)First quarter 2023 results: EPS: PK₨2.96 (up from PK₨0.13 in 1Q 2022). Revenue: PK₨1.70b (up 116% from 1Q 2022). Net income: PK₨518.8m (up PK₨496.4m from 1Q 2022). Profit margin: 31% (up from 2.8% in 1Q 2022). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 21% per year whereas the company’s share price has increased by 19% per year.
Upcoming Dividend • Oct 03Upcoming dividend of PK₨2.00 per shareEligible shareholders must have bought the stock before 10 October 2022. Payment date: 10 November 2022. Payout ratio is a comfortable 74% and this is well supported by cash flows. Trailing yield: 9.4%. Lower than top quartile of Pakistani dividend payers (11%). Lower than average of industry peers (12%).
Reported Earnings • Sep 28Full year 2022 earnings released: EPS: PK₨2.69 (vs PK₨1.59 in FY 2021)Full year 2022 results: EPS: PK₨2.69 (up from PK₨1.59 in FY 2021). Revenue: PK₨4.25b (up 52% from FY 2021). Net income: PK₨470.9m (up 69% from FY 2021). Profit margin: 11% (up from 9.9% in FY 2021). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 5% per year but the company’s share price has increased by 18% per year, which means it is well ahead of earnings.
Valuation Update With 7 Day Price Move • Aug 03Investor sentiment improved over the past weekAfter last week's 17% share price gain to PK₨17.50, the stock trades at a trailing P/E ratio of 9.3x. Average trailing P/E is 5x in the Chemicals industry in Pakistan. Total returns to shareholders of 62% over the past three years.
Reported Earnings • Apr 30Third quarter 2022 earnings released: EPS: PK₨0.15 (vs PK₨0.75 in 3Q 2021)Third quarter 2022 results: EPS: PK₨0.15 (down from PK₨0.75 in 3Q 2021). Revenue: PK₨982.1m (up 24% from 3Q 2021). Net income: PK₨25.7m (down 80% from 3Q 2021). Profit margin: 2.6% (down from 17% in 3Q 2021). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has fallen by 22% per year but the company’s share price has increased by 2% per year, which means it is well ahead of earnings.
Board Change • Apr 27Less than half of directors are independentThere is 1 new director who has joined the board in the last 3 years. The new board member was not an independent director. The company's board is composed of: 1 new director. 6 experienced directors. 1 highly experienced director. 3 independent directors (5 non-independent directors). Independent Director Haroon Waheed was the last independent director to join the board, commencing their role in 2018. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.
Reported Earnings • Feb 21Second quarter 2022 earnings: Revenues and EPS in line with analyst expectationsSecond quarter 2022 results: EPS: PK₨1.36 (up from PK₨0.52 in 2Q 2021). Revenue: PK₨1.14b (up 61% from 2Q 2021). Net income: PK₨238.1m (up 162% from 2Q 2021). Profit margin: 21% (up from 13% in 2Q 2021). The increase in margin was driven by higher revenue. Revenue was in line with analyst estimates. Over the last 3 years on average, earnings per share has fallen by 28% per year but the company’s share price has remained flat, which means it is well ahead of earnings.
Reported Earnings • Oct 27First quarter 2022 earnings released: EPS PK₨0.13 (vs PK₨0.099 in 1Q 2021)The company reported a strong first quarter result with improved earnings, revenues and profit margins. First quarter 2022 results: Revenue: PK₨788.3m (up 27% from 1Q 2021). Net income: PK₨22.4m (up 59% from 1Q 2021). Profit margin: 2.8% (up from 2.3% in 1Q 2021). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 34% per year but the company’s share price has only fallen by 10% per year, which means it has not declined as severely as earnings.
Upcoming Dividend • Oct 07Upcoming dividend of PK₨1.00 per shareEligible shareholders must have bought the stock before 14 October 2021. Payment date: 15 November 2021. Trailing yield: 4.4%. Lower than top quartile of Pakistani dividend payers (10%). Lower than average of industry peers (11%).
Reported Earnings • Sep 09Full year 2021 earnings released: EPS PK₨1.59 (vs PK₨2.95 in FY 2020)The company reported a soft full year result with weaker earnings and profit margins, although revenues improved. Full year 2021 results: Revenue: PK₨2.80b (up 6.2% from FY 2020). Net income: PK₨278.7m (down 33% from FY 2020). Profit margin: 9.9% (down from 16% in FY 2020). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has fallen by 26% per year but the company’s share price has only fallen by 2% per year, which means it has not declined as severely as earnings.
Reported Earnings • Apr 24Third quarter 2021 earnings released: EPS PK₨0.75 (vs PK₨0.81 in 3Q 2020)The company reported a solid third quarter result with improved earnings and revenues, although profit margins were weaker. Third quarter 2021 results: Revenue: PK₨793.1m (up 11% from 3Q 2020). Net income: PK₨130.7m (up 2.7% from 3Q 2020). Profit margin: 17% (down from 18% in 3Q 2020). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has fallen by 13% per year but the company’s share price has increased by 13% per year, which means it is well ahead of earnings.
Valuation Update With 7 Day Price Move • Mar 10Investor sentiment deteriorated over the past weekAfter last week's 20% share price decline to PK₨23.43, the stock is trading at a trailing P/E ratio of 10.5x, down from the previous P/E ratio of 13.1x. This compares to an average P/E of 9x in the Chemicals industry in Pakistan. Total returns to shareholders over the past three years are 54%.
Reported Earnings • Feb 28Second quarter 2021 earnings released: EPS PK₨0.52 (vs PK₨0.75 in 2Q 2020)The company reported a decent second quarter result with improved earnings and profit margins, although revenues were weaker. Second quarter 2021 results: Revenue: PK₨705.0m (down 5.0% from 2Q 2020). Net income: PK₨90.9m (up 2.9% from 2Q 2020). Profit margin: 13% (up from 12% in 2Q 2020). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has fallen by 4% per year but the company’s share price has increased by 23% per year, which means it is well ahead of earnings.
Is New 90 Day High Low • Feb 20New 90-day low: PK₨30.83The company is down 5.0% from its price of PK₨32.33 on 20 November 2020. The Pakistani market is up 12% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 6.0% over the same period.
Reported Earnings • Oct 26First quarter earnings releasedOver the last 12 months the company has reported total profits of PK₨378.3m, up 74% from the prior year. Total revenue was PK₨2.63b over the last 12 months, up 1.2% from the prior year.
Reported Earnings • Oct 02Full year earnings released - EPS PK₨3.42Over the last 12 months the company has reported total profits of PK₨418.4m, up 6.6% from the prior year. Total revenue was PK₨2.64b over the last 12 months, down 2.3% from the prior year. Profit margins were 16%, which is higher than the 14% margin from last year. The increase in margin was driven by lower expenses.
Is New 90 Day High Low • Sep 25New 90-day high: PK₨48.36The company is up 67% from its price of PK₨28.97 on 26 June 2020. The Pakistani market is up 21% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 10.0% over the same period.
